Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
ARTV Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/artv/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Artiva Biotherapeutics, Inc. (ARTV) Insider Trading

28 open-market trades reported since Jun 16, 2026: 16 purchases worth $10.0M and 12 sales worth $2.00M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Fred AslanCEO0$04$1.54MOct 7, 2026
Christopher HoranChief Tech Operations Officer0$02$186KOct 6, 2026
Jennifer BushCOO0$02$151KOct 6, 2026
Subhashis BanerjeeChief Medical Officer0$04$124KOct 6, 2026
Ra Capital Management, L.P.Director16$10.0M0$0Jul 31, 2026

All trades

ARTV insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHolding3 mo. afterFiling
Oct 7Oct 6Fred AslanCEOCEO▼ SELL10b5-123,4637.20$169K−1.5%Form 4 ↗
Oct 6Oct 5Fred AslanCEOCEO▼ SELL61,6966.84$422K−3.8%Form 4 ↗
Oct 6Oct 5Christopher HoranChief Tech Operations OfficerChief Tech Operations Officer▼ SELL10,3406.84$71K−3.2%Form 4 ↗
Oct 6Oct 5Jennifer BushCOOCOO▼ SELL8,3706.84$57K−2.2%Form 4 ↗
Oct 6Oct 5Subhashis BanerjeeChief Medical OfficerChief Medical Officer▼ SELL1,0996.84$8K−0.6%Form 4 ↗
Sep 9Sep 8Fred AslanCEOCEO▼ SELL10b5-123,42910.92$256K−1.6%Form 4 ↗
Sep 4Sep 3Fred AslanCEOCEO▼ SELL61,88811.16$690K−4.0%Form 4 ↗
Sep 4Sep 3Christopher HoranChief Tech Operations OfficerChief Tech Operations Officer▼ SELL10,36611.16$116K−3.5%Form 4 ↗
Sep 4Sep 3Jennifer BushCOOCOO▼ SELL8,39111.16$94K−2.5%Form 4 ↗
Sep 4Sep 3Subhashis BanerjeeChief Medical OfficerChief Medical Officer▼ SELL1,10011.16$12K−0.8%Form 4 ↗
Aug 31Aug 27Subhashis BanerjeeChief Medical OfficerChief Medical Officer▼ SELL10b5-18,22212.01$99K−5.5%Form 4 ↗
Aug 19Aug 18Subhashis BanerjeeChief Medical OfficerChief Medical Officer▼ SELL10b5-142912.00$5K−0.3%Form 4 ↗
Jul 31Jul 31Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY24,9449.93$248K26+0.1%Form 4 ↗
Jul 31Jul 29Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY20,8249.99$208K26+0.1%Form 4 ↗
Jul 28Jul 24Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY41,3199.99$413K30+0.2%Form 4 ↗
Jul 23Jul 21Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY120,5829.55$1.15M37+0.7%Form 4 ↗
Jul 23Jul 22Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY84,1249.93$835K34+0.5%Form 4 ↗
Jul 23Jul 23Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY59,8809.96$596K34+0.3%Form 4 ↗
Jul 23Jul 13Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY6,5228.94$58K12+0.0%Form 4 ↗
Jul 20Jul 16Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY152,4728.93$1.36M26+0.9%Form 4 ↗
Jul 20Jul 17Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY7,8828.95$71K12+0.0%Form 4 ↗
Jul 14Jul 10Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY15,1028.97$135K19+0.1%Form 4 ↗
Jul 14Jul 13Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY6,5528.94$59K12+0.0%Form 4 ↗
Jun 29Jun 25Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY31,0008.88$275K19+0.2%−3.0%Form 4 ↗
Jun 29Jun 26Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY1,8768.98$17K9+0.0%−4.1%Form 4 ↗
Jun 16Jun 12Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY391,0198.57$3.35M26+2.4%+21.6%Form 4 ↗
Jun 16Jun 16Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY124,8938.89$1.11M26+0.8%−3.1%Form 4 ↗
Jun 16Jun 15Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY15,4148.99$139K19+0.1%−4.2%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings